| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Chief Scientific Officer
1 company
Mor George Adi is a Chief Executive Officer at Chemomab Therapeutics Ltd.. Recent SEC Form 4 filings include 2 buys and 4 sells.
Estimated insider holdings value: $204K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 29, 2026 | CMMB Chemomab Therapeutics Ltd. | Chief Executive Officer | Buy | 9,804 | $2.07 | $20,245.98 | +3.7% | - | - | |
| Jan 3, 2023 | CMMB Chemomab Therapeutics Ltd. | Chief Scientific Officer | Sell | 13,800 | $5.03 | $69,369.84 | -2.4% | -49.0% | -81.8% | |
| Nov 16, 2022 | CMMB Chemomab Therapeutics Ltd. | Chief Scientific Officer | Sell | 582,023 | $2.08 | $1,213,401.55 | -50.0% | -9.2% | -71.1% |